Clarius Group LLC Raises Stake in Axon Enterprise, Inc $AXON

Clarius Group LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 5.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,822 shares of the biotechnology company’s stock after buying an additional 156 shares during the period. Clarius Group LLC’s holdings in Axon Enterprise were worth $2,336,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of AXON. TCTC Holdings LLC raised its holdings in Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC lifted its position in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after buying an additional 33 shares during the period. Banque Transatlantique SA purchased a new position in Axon Enterprise during the first quarter worth about $31,000. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the 1st quarter valued at about $32,000. Finally, Flaharty Asset Management LLC acquired a new position in shares of Axon Enterprise during the 1st quarter valued at about $33,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the sale, the chief executive officer directly owned 3,053,982 shares in the company, valued at approximately $2,538,744,696.78. This trade represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 49,932 shares of company stock worth $37,978,216 in the last quarter. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $715.51 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The firm has a market capitalization of $56.17 billion, a PE ratio of 176.67, a P/E/G ratio of 27.78 and a beta of 1.41. Axon Enterprise, Inc has a 1-year low of $413.68 and a 1-year high of $885.91. The business’s fifty day moving average price is $757.79 and its two-hundred day moving average price is $708.33.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. During the same quarter in the prior year, the firm earned $1.20 earnings per share. The company’s quarterly revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. JMP Securities reiterated a “market outperform” rating and set a $825.00 price objective on shares of Axon Enterprise in a report on Monday, September 29th. Wolfe Research initiated coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They set an “outperform” rating on the stock. Piper Sandler assumed coverage on shares of Axon Enterprise in a report on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 price target on the stock. Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective for the company in a report on Tuesday, August 5th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.